Download Files:
Products Details
Product Description
– KRAS G12C inhibitor 34 is a KRAS G12C inhibitor extracted from patent WO2021239058A1, compound Z1. KRAS G12C inhibitor 34 can be used for the research of cancer[1].
Web ID
– HY-142511
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C32H32ClN5O3
References
– [1]Zhou FS, et, al. Fused tricyclic compound, pharmaceutical composition thereof, and use thereof. WO2021239058A1.
CAS Number
– 2749948-26-1
Molecular Weight
– 570.08
SMILES
– O=C1N2[C@@](CN(C(C=C)=O)CC2)([H])COC3=C(Cl)C(C4=C(C)C=CC5=C4C=NN5)=CC(NC6=CC=CC=C6C(C)C)=C13
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Ras
Pathway
– GPCR/G Protein
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
